Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis

World Journal of Gastroenterology

Volumn 14, Issue 13, 2008, Pages 2100-2105

  Wu, Xiao Ling ^a   Zeng, Wei Zheng ^a   Jiang, Ming De ^a   Qin, Jian Ping ^a   Xu, Hui ^a  

^a CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Hepatic Fibrosis; Oxymatrine; TGF Smad signaling

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; HEMATOXYLIN; MESSENGER RNA; OXYMATRINE; SMAD PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER FIBROSIS; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SIGNAL TRANSDUCTION; STAINING;

EID: 44849092456     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.2100     Document Type: Article

References (30)

1. Albanis E, Friedman SL. Antifibrotic agents for liver disease. Am J Transplant 2006; 6: 12-19
2. Gressner AM, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J Cell Mol Med 2006; 10: 76-99
3. Li Z, Dranoff JA, Chan EP, Uemura M, Sevigny J, Wells RG. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology 2007; 46: 1246-1256
4. Parsons CJ, Takashima M, Rippe RA. Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol 2007; 22 Suppl 1: S79-S84
5. Prosser CC, Yen RD, Wu J. Molecular therapy for hepatic injury and fibrosis: where are we? World J Gastroenterol 2006; 12: 509-515
6. Liang KH, Li SB. Animal model of Portal hypertension, Portal hypertension. 1st ed. People's Sanitary Pub, 1999: 413
7. Wang BY, Li YS, Huang GS, Zhang YQ. Common special staining methods. Pathological technique. 1st ed. People's Sanitary Pub, 2000: 140-147
8. Liang KH, Li SB. Histological stages of chronic hepatitis, Hepatology. 2nd ed. People's Sanitary Pub, 2003: 729-731
9. Wang BY, Li YS, Huang GS. Technique of in situ hybridization Pathological technique. 1st ed. People's Sanitary Pub,2000: 565-570
10. Wang BY, Li YS, Huang GS. Immunohistochemistry Pathological technique. 1st ed. People's Sanitary Pub, 2000: 354-378
11. Louis H, Le Moine O, Goldman M, Deviare J. Modulation of liver injury by interleukin-10. Acta Gastroenterol Belg 2003; 66: 7-14
12. Rockey DC. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol 2005; 3: 95-107
13. Wu XL, Zeng WZ, Wang PL, Lei CT, Jiang MD, Chen XB, Zhang Y, Xu H, Wang Z. Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms. World J Gastroenterol 2003; 9: 1559-1562
14. Zhang G, Zhang FC, Wang TC, Liang KH. The effects of Chinese national medicine of Huoxueruanjian compound on SMAD signal in hepatic stellate cell and its significance. Zhonghua Ganzangbing Zazhi 2004; 12: 213-215
15. Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 2002; 35: 49-61
16. Schiller M, Javelaud D, Mauviel A. TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci 2004; 35: 83-92
17. Zimowska M. Signaling pathways of transforming growth factor beta family members. Postepy Biochem 2006; 52: 360-366
18. Feng XH, Derynck R. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 2005; 21: 659-693
19. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TCF-beta family signalling. Nature 2003; 425: 577-584
20. Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y, Han Y, Feng XH, Meng A, Chen YG. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol 2007; 27: 4488-4499
21. Itoh S, ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol 2007; 19: 176-184
22. Runyan CE, Poncelet AC, Schnaper HW. TGF-beta receptor-binding proteins: complex interactions. Cell Signal 2006; 18: 2077-2088
23. Xu L. Regulation of Smad activities. Biochim Biophys Acta 2006; 1759: 503-513
24. Hill CS. Identification of a Smad phosphatase. ACS Chem Biol 2006; 1: 346-348
25. Wicks SJ, Grocott T, Haros K, Maillard M, ten Dijke P, Chantry A. Reversible ubiquitination regulates the Smad/TGF-beta signalling pathway. Biochem Soc Trans 2006; 34: 761-763
26. Verrecchia F, Mauviel A. Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 2002; 118: 211-215
27. Verrecchia F, Mauviel A. Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis. Curr Rheumatol Rep 2002; 4: 143-149
28. Zhang F, Laiho M. On and off: proteasome and TGF-beta signaling. Exp Cell Res 2003; 291: 275-281
29. Lu LG, Zeng MD, Mao YM, Wan MB, Li CZ, Chen CW, Fu QC, Wang JY, She WM, Cai X, Ye J, Zhou XQ, Wang H, Wu SM, Tang MF, Zhu JS, Chen WX. Oxymatrine in the treatment of chronic hepatitis B for one year: a multicenter random double-blind placebo-controlled trial. Zhonghua Ganzangbing Zazhi 2004; 12: 597-600
30. Liu J, Shi BN, He JF. Effect of oxymatrine on serum matrix metalloproteinase-2 and its inhibitor in patients with chronic hepatitis B and liver cirrhosis. Zhongguo Zhongxiyi Jiehe Zazhi 2005; 25: 989-992